BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29939423)

  • 1. Emerging areas of opioid pharmacology.
    Kelly E; Henderson G; Bailey CP
    Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid research in the time of the opioid crisis.
    Traynor JR; Moron JA
    Br J Pharmacol; 2023 Apr; 180(7):793-796. PubMed ID: 36813266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting multiple opioid receptors - improved analgesics with reduced side effects?
    Günther T; Dasgupta P; Mann A; Miess E; Kliewer A; Fritzwanker S; Steinborn R; Schulz S
    Br J Pharmacol; 2018 Jul; 175(14):2857-2868. PubMed ID: 28378462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamic interaction between pain and opioid misuse.
    Wilson-Poe AR; Morón JA
    Br J Pharmacol; 2018 Jul; 175(14):2770-2777. PubMed ID: 28602044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of opioids on immune function in patients with cancer pain: from bench to bedside.
    Boland JW; Pockley AG
    Br J Pharmacol; 2018 Jul; 175(14):2726-2736. PubMed ID: 28593737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioids and the immune system - friend or foe.
    Plein LM; Rittner HL
    Br J Pharmacol; 2018 Jul; 175(14):2717-2725. PubMed ID: 28213891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic acetylcholine receptors.
    Wonnacott S; Bermudez I; Millar NS; Tzartos SJ
    Br J Pharmacol; 2018 Jun; 175(11):1785-1788. PubMed ID: 29878346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the mechanisms underlying opioid use disorder and potential treatment strategies.
    Cao DN; Li F; Wu N; Li J
    Br J Pharmacol; 2023 Apr; 180(7):862-878. PubMed ID: 34128238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures.
    Marino KA; Shang Y; Filizola M
    Br J Pharmacol; 2018 Jul; 175(14):2834-2845. PubMed ID: 28266020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pharmacology of G protein-coupled receptors.
    Summers RJ
    Br J Pharmacol; 2016 Oct; 173(20):2931-3. PubMed ID: 27682321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting inflammation to reduce cardiovascular disease risk.
    Maffia P; Cirino G
    Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of opioid receptor heteromers in chronic pain and associated comorbidities.
    Gaborit M; Massotte D
    Br J Pharmacol; 2023 Apr; 180(7):994-1013. PubMed ID: 34883528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Research: Past and Future.
    Valentino RJ; Volkow ND
    Mol Pharmacol; 2020 Oct; 98(4):389-391. PubMed ID: 32660966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anomalous pharmacology of fentanyl.
    Kelly E; Sutcliffe K; Cavallo D; Ramos-Gonzalez N; Alhosan N; Henderson G
    Br J Pharmacol; 2023 Apr; 180(7):797-812. PubMed ID: 34030211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allostery at opioid receptors: modulation with small molecule ligands.
    Livingston KE; Traynor JR
    Br J Pharmacol; 2018 Jul; 175(14):2846-2856. PubMed ID: 28419415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT signalling: mechanisms and therapeutic opportunities.
    Schulte G; Bryja V
    Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies towards safer opioid analgesics-A review of old and upcoming targets.
    Varga BR; Streicher JM; Majumdar S
    Br J Pharmacol; 2023 Apr; 180(7):975-993. PubMed ID: 34826881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid system and human emotions.
    Nummenmaa L; Tuominen L
    Br J Pharmacol; 2018 Jul; 175(14):2737-2749. PubMed ID: 28394427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders.
    Alvarez-Perez B; Poras H; Maldonado R
    Br J Pharmacol; 2023 Apr; 180(7):879-893. PubMed ID: 34378790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pharmacology of GPCRs.
    Langmead CJ; Summers RJ
    Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.